Kintara Therapeutics Inc (KTRA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Kintara Therapeutics Inc.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 63 days, KTRA's average price target has gone up $0.31.
KTRA reports an average of 189.65% for its upside potential over the past 109 days.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
KTRA Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- The upside potential (average analyst target price relative to current price) of KTRA is greater than 94.17% of all US stocks.
- KTRA has a greater average analyst price target than 10.66% of all US stocks.
- The number of analysts covering the stock of KTRA is higher than 84.19% of stocks in the micro market cap category.
- Kintara Therapeutics Inc's variance in analysts' estimates is less than 20.76% of stocks in the micro market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Kintara Therapeutics Inc are SRNE, HEPA and COCP.
What is the outlook for KTRA? Use POWR Ratings for clearer insight into price direction.